Surveillance for hepatocellular carcinoma... A hotly debated issue

Acta Gastro-Enterologica Belgica

Volumn 67, Issue 3, 2004, Pages 255-264

  Henrion, J ^a,b  

^a Division of Hepato Gastroenterology   (Belgium)

^b Hospital de Jolimont   (Belgium)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Screening; Surveillance

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; EARLY DIAGNOSIS; HEPATITIS C; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRACTICE GUIDELINE; PREVALENCE; REVIEW;

BELGIUM; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MASS SCREENING; POPULATION SURVEILLANCE;

EID: 8444243330     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. KANE M., ALTER M., ESTEBAN R., RIZZETTO M. Role of screening in prevention and treatment. Gut, 1993, supplement: S45-S47.
2. COLLIER J., SHERMAN M. Screening for hepatocellular carcinoma. Hepatology, 1998, 27: 274-278.
3. ROGET L., COPPÉRÉ H., RICHARD P., BARTHÉLÉMY C., VEYRET C., AUDIGIER J.-C. Dépistage échographique du carcinome hépatocellulaire chez les patients hospitalisés pour cirrhose. Gastroenterol. Clin. Biol., 1988, 12: 827-832.
4. LARCOS G., SOROKOPUD H., BERRY G., FARRELL G. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: An evaluation. Am. J. Roentgenol., 1998, 171: 433-435.
5. IZZO F., CREMONA F., RUFFOLO F., PALAIA R., PARISI V., CURLEY S. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Am. Surg., 1998, 227: 513-518.
6. CHALASANI N., HORLANDER J., SAID A., HOEN H., KOPECKY K., STOCKBERGER S., MANAM R., KWO P., LUMENG L. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am. J. Gastroenterol., 1999, 94: 2988-2993.
7. GANNE-CARRIÉ N., CHEVRET S., BARBARE J.-C., CHAFFAUD C., GRANDO V., VOGT A.-M., BEAUGRAND M., TRINCHET J.-C. Dépistage et traitement précoce du carcinome hépatocellulaire. Enquête concernant les intentions des hépato-gastroentérologues hospitaliers en France. Gastroenterol. Clin. Biol., 2002, 26: 570-577.
8. CHALASANI N., SAID A., NESS R., HOEN H., LUMENG L. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am. J. Gastroenterol., 1999, 94: 2224-2229.
9. WILSON J., JUNGER G. The principles and practice of screening for disease. Public Health Papers 34, Geneva, WHO 1968.
10. NGUYEN M., KEEFFE E. Screening for hepatocellular carcinoma. J. Clin. Gastroenterol., 2002, 35 (suppl 2): S86-S91.
11. LONDON T., MEGLYNN K. Liver cancer in D. SCHOTTENFELD and J. FRAUMENI, cancer epidemiology and prevention, Oxford University Press, New-York, 1996.
12. MEGLYNN K., TSAO L., HSING A., DEVESA S., FRAUMENI J. International trends and patterns of primary liver cancer. Int. J. Cancer, 2001, 90: 290-296.
13. CHEN Z.-N., LIU B.-Q., BOREHAM J., WU Y.-P., CHEN J.-S., PETO R. Smoking and liver cancer in China: case-control comparison of 36 000 liver cancer deaths versus 17 000 cirrhosis deaths. Int. J. Cancer, 2003, 107: 106-112.
14. LA VECCHIA C., LUCCHINI F., FRANCESCHI S., NEGRI E., LEVI F. Trends in mortality from primary liver cancer in Europe. Eur. J. Cancer, 2000, 36: 909-915.
15. DEUFFIC S., POYNARD T., BUFFAT L., VALLERON A.-J. Trends in primary liver cancer. Lancet, 1998, 351: 214-215.
16. TAYLOR-ROBINSON S., FOSTER R., ARORA S., HARGREAVES S., THOMAS H. Increase in primary liver cancer in the UK, 1979-94. Lancet, 1997, 350: 1142-1143.
17. KACZYSNKI J., ODEN A. Increasing incidence of primary liver cancer - A matter of aging? Gastrointest. cancer, 1999, 3: 67-71.
18. YOSHIZAWA H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future. Oncology, 2002, 62 (suppl 1): 8-17.
19. EL-SERAG H., MASON A. Rising incidence of hepatocellular carcinoma in the United States. N. Engl., J. Med., 1999, 340: 745-750.
20. EL-SERAG H., MASON A. Risk factors for the rising rates of primary liver cancer in the United States. Arch. Intern. Med., 2000, 180: 3227-3230.
21. JOHNSON P., WILLIAMS R. Cirrhosis and the etiology of hepatocellular carcinoma. J. Hepatol., 1987, 4: 140-147.
22. CALVET X., BRUIX J., BRU C., GINES P., VILANA R., SOLE M., AYUSO M., BRUGUERA M., RODES J. Natural history of hepatocellular carcinoma in Spain. J. Hepatol., 1990, 10: 311-317.
23. THE CANCER OF THE LIVER ITALIAN PROGRAM (CLIP) INVESTIGATORS. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology, 1998, 28: 751-755.
24. OKUDA K., NAKASHIMA T., KOJIRO M., KONDO Y., WADA K. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology, 1989, 97: 140-146.
25. KALAYCI C., JOHNSON P., DAVIES S., WILLIAMS R. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J. Hepatol., 1991, 12: 54-59.
26. BRALET M.-P., REGIMBEAU J.-M., PINEAU P., DUBOIS S., LOAS G., DEGOS F., VALLA D., BELGHITI J., DEGOTT C., TERRIS B. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 french cases. Hepatology, 2000, 32: 200-204.
27. LIN D., LIAW Y.-F., CHU C., CHANG-CHIEN C., WU C., CHEN P., SHEEN S. Hepatocellular carcinoma in non-cirrhotic patients. Cancer, 1984, 54: 1466-1468.
28. KEW M. Hepatocellular carcinoma with and without cirrhosis. A comparison in southern african blacks. Gastroenterology, 1989, 97: 136-139.
29. OMATA M., TAKANO S. Occurrence of hepatocellular in chronic viral hepatitis. Cancer Chemother. Pharmacol., 1994, 33 (suppl): S 153-S 154.
30. CHEN C.-J., WANG L.-Y., LU S.-N., WU M.-H., YOU S.-L., ZHANG Y.-J., WANG L.-W., SANTELLA R. Elevated alphatoxin exposure and increase risk of hepatocellular carcinoma. Hepatology, 1996, 24: 38-42.
31. BRECHOT C., JAFFREDO F., LAGORCE D., GERKEN G., MEYER ZUN BÜSCHENFELDE K., PAPAKONSTONTINOU A., HADZIYANNIS S., ROMEO R., COLOMBO M., RODES J., BRUIX J., WILLIAMS R., NAOUMOV N. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinoma in Europe: results of an european concerted action. J. Hepatol., 1998, 29: 173-183.
32. POYNARD T., AUBERT A., LAZIZI Y., BEDOSSA P., HANELIN B., TERRIS B., NAUPAU S., DUBREUIL P., PILLOT J., CHAPUT J.-C. Independent risk factors for hepatocellular carcinoma in french drinkers. Hepatology, 1991, 13: 896-901.
33. KUPER H., YE W., BROONE U., ROMELSJO A., MUCCI L., EKBOM A., ADAMI H.-O., TRICHOPOULOS O., NYREN O. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism or cirrhosis. Hepatology, 2001, 34: 714-718.
34. KOBAYASHI K., SUGIMOTO T., MAKINO A., KUNAGAI H.-O., UNOURA M., TANAKA N., KATO Y., HATTORI N. Screening methods for early detection of hepatocellular carcinoma. Hepatology, 1985, 5: 1100-1105.
35. OKA H., KURIOKA N., KIM K., KANNO T., KUROKI T., MIZOGUCHI Y., KOBAYASHI K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology, 1990, 12: 680-687.
36. COLOMBO M., DE FRANCHIS R., DEL NINNO E., SANGIOVANNI A., DE FAZIO C., TOMMASINI M., DONATO F., PIVA A., DI CARLO Y., DIOGUARDI N. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med., 1991, 325: 675-680.
37. IMBERTI D., FORNARI F., SBOLLI G., BUSCARINI E., SQUASSANTE L., BUSCARINI L. Hepatocellular carcinoma in liver cirrhosis. A prospective study. Scand. J. Gastroenterol., 1993, 28: 540-544.
38. TSUKUMA I., HIYANA T., TANAKA S., NAKAO H., YABUUCHI T., KITANURA T., NAKANISHI K., FUJIMOTO I., INOUE A., YANAZAKI H., KAWASHIMA T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med., 1993, 328: 1797-1801.
39. IKEDA K., SAITOH S., KOIDA I., ARASE Y., TSUBOTA., CHAYAMA K., KUMADA H., KAWANISHI N. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology, 1993, 18: 47-53.
40. SATO Y., NAKATA K., KATO Y., SHIMA M., ISHII N., KOJI T., TAKETA K., ENDO Y., NAGATAKI S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-foetoprotein. N. Engl. J. Med., 1993, 328: 1802-1806.
41. COTTONE M., TURRI M., CALTAGIRONE M., PARISI P., ORLANDO A., FIORENTINO G., VIRDONE R., FUSCO G., GRASSO R., SIMONETTI G., PAGLIARO L. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: on 8-year prospective study by ultrasound and alpha-foetoprotein. J. Hepatol., 1994, 21: 1029-1034.
42. PATERON D., GANNE N., TRINCHET J.-C., AUROUSSEAU M.-H., MAL F., MEICLER C., CODERC E., REBOULLET P., BEAUGRAND M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J. Hepatol., 1994, 20: 65-71.
43. FATTOVICH G., GIUSTINA C., SCHALM S., HADZIYANNIS S., SANCHEZ-TAPIAS J., ALMASIO P., CHRISTENSEN E., KROGSGAARD K., DEGOS F., CARNEIRO DE MOURA M., SOLINAS A., NOVENTA F., REALDI G., and the EUROHEP Study Group on hepatitis B virus and cirrhosis. - Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology, 1995, 21: 77-82.
44. ZOLI M., MAGALOTTI D., GUELLI C., MARCHESINI G., PISI E. Efficiency of a surveillance program for early detection of hepatocellular carcinoma. Cancer, 1996, 78: 977-985.
45. SOLMI L., MANILA PRIMERANO A.-M., GANDOLFI L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases. Am. J. Gastroenterol., 1996, 91: 1189-1194.
46. FATTOVICH G., GIUSTINA G., DEGOS F., TREMOLAO A., DIODATI G., ALMASIO P., NEVENS F., SOLINAS A., MURA O., BROUWE J., THOMAS H., NJAPOUH C., CASARIN C., BONETTI P., FUSCHI P., BASHO J., TOCCO A., BHALLA A., GALA SPINI R., NOVENTA F., SCHALM S., REALDI G. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology, 1997, 112: 463-472.
47. SERFATY L., AUMAITRE H., CHAZOUILLERES O., BONNAND A.-M., ROSMORDUC O., POUPON R.E., POUPON R. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology, 1998, 27: 1435-1440.
48. DEGOS F., CHRISTIDIS C., GANNE-PARRIE N., FARMACHIDI J.-P., DEGOTT C., GUETTIER C., TRINCHET J.-C., BEAUGRAND M., CHEURET S. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut, 2000, 47: 131-136.
49. BOLONDI L., SOFIA S., SIRINGO S., GAIANI S., CASALI A., ZIRONI G., PISCAGLIA F., GRAMANTIERI L., ZANETTI M., SHERMAN M. Surveillance program of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut, 2001, 48: 251-259.
50. CATURELLI E., BARTOLUCCI F., BIASINI E., VIGLIOTTI M.-L., ANDRIULLI A., SIENA D A., ATTINO U., BISCEGLIA M. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Ann. J. Gastroenterol., 2002, 97: 397-405.
51. VELAZQUEZ R., RODRIGUEZ H., NAVASCUES C., LINARES A., PEREZ R., SOTORRIOS N., MARTINEZ I., RODRIGO L. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology, 2003, 37: 520-527.
52. HENRION J., LIBON E., DE MAEGHT S., DELTENRE P., SCHAPIRA M., GHILAIN J.-M., MAISIN J.-M., HELLER F. Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose d'origine principalement alcoolique. Gastroenterol. Clin. Biol., 2003, 27: 534-539.
53. OKA H., TAMORI A., KUROKI T., KOBAYASHI K., YAHAMOTO S. Prospective study of α-foetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology, 1994, 19: 61-66.
54. LIAW Y.-F., TAI D.-I., CHU C.-M., LIN D.-Y., SHEEN I.-S., CHEN T.-J., PAO C.C. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis - A prospective study. Gastroenterology, 1986, 90: 263-267.
55. SHERMAN M., PELTEKIAN K., LEE C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North America urban population. Hepatology, 1995, 22: 432-438.
56. IKEDA K., SAITOH S., SUZUKI Y., KOBAYASHI M., TSUBOTA A., KOIDA I., ARASE Y., FUKUDA M., CHAYAMA K., MURASHIMA N., KUMADA H. Disease progression and hepatocellular carcinogenese in patients with chronic viral hepatitis: a prospective observation of 2218 patients. J. Hepatol., 1998, 28: 930-938.
57. YANG H.-I., LU S.-N., LIAW Y.-F., YOU S.-L., SUN C.-A., WANG L.-Y., HSIAO C., CHEN P.-J., CHEN D.-S., CHEN C.-J. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med., 2002, 347: 168-174.
58. LOK A., LAI C.-L. Factors determining the development of hepatocellular carcinoma in hepatitis B surface antigen carriers. Cancer, 1988, 61: 1287-1291.
59. HENRION J., DE MAEGHT S., DELTENRE P., CHILAIN J.-M., MAISIN J.-M., SCHAPIRA M., HELLER F. Impact of hepatitis C virus infection on the aetiology of cirrhosis and hepatocarcinoma in the affiliated hospitals in Southern Belgium. Acta Gastroenterol. Belg., 2002, 65: 80-82.
60. VAN GOSSUM A., DUBOIS P., LAURENT E., REDING P., BURETTE A., ADLER M., CREMER M. Les caractéristiques cliniques, biologiques et épidémiologiques des hépatocarcinomes dans la région bruxelloise. Acta Gastroenterol. Belg., 1985, 48: 337-351.
61. HENRION J., LIBON E., DE MAEGHT S., SCHAPIRA M., GHILAIN J.-M., MAISIN J.-M., HELLER F. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. Acta Gastroenterol. Belg., 2000, 63: 5-9.
62. NAOUMOV N., CHOKSHI S., METIVIER E., MAERTENS G., JOHNSON P., WILLIAMS R. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J. Hepatol., 1997, 27: 331-336.
63. HAYDON G., JARVIS L., SIMMONDS P., HARRISON D., GARDEN O., HAYES P. Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. Gut, 1997, 40: 128-132.
64. SCHÖNIGER-HEKELE M., MÜLLER C., KUTILEK M., OESTERREICHER C., FERENO P., GANGI A. Hepatocellular carcinoma in central Europe: prognostic feature and survival. Gut, 2001, 48: 103-109.
65. CALVET X., BRUIX J., GINES P., BRU C., SOLE M., VILANA R., RODES J. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology, 1990, 12: 753-763.
66. OKUDA K., OHTSUKI T., OBATA H., TOMINATSU M., OKAZAKI N., HASEGAWA H., NAKAJIMA Y., OHNISHI K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer, 1985, 56: 912-928.
67. COLOMBO M. The natural history of hepatocellular carcinoma in western countries. Hepato-Gastroenterol., 1998, 45: 1221-1225.
68. SHEU J.-C., LUNG J.-R., CHEN D.-S., YANG P.-M., LAI M.-Y., LEE C.-S., HSU H.-C., CHUANG C.-N., YANG P.-C., WANG T.-H., LIN J.-T., LEE C.-Z. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology, 1985, 89: 259-266.
69. EBARA M., OHTO M., SHINAGAWA T., SUGIURA N., KIMURA K., MATSUTANI S., MORITA M., SAISHO H., TSUCHIYA Y., OKUDA K. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology, 1986, 90: 289-298.
70. OKAZAKI N., YOSHINO M., YOSHIDA T., SUZUKI M., MORIYAMA N., TAKAYASU K., MAKUUCHI M., YAMAZAKI S., HASEGAWA H., NOGUCHI M., HIROHASHI S. Evolution of the prognosis for small hepatocellular carcinoma based on tumour volume doubling time. Cancer, 1989, 63: 2207-2210.
71. BARBARA L., BENZI G., GAIANI S., FUSCONI F., ZIRONI G., SIRINGO S., RIGAMONTI A., BARBARA C., GRIGIONI W., MAZZIOTTI A., BOLONDI L. Natural history of small untreated hepatocellular carcinoma in cirrhosis. A multivariate analysis of prognostic factors of tumour growth rate and patient survival. Hepatology, 1992, 16: 132-137.
72. KUBOTA K., INA Y., IRIE T. Growth rate of primary single hepatocellular carcinoma: determining optional screening interval with contrast enhanced computed tomography. Dig. Dis. Sci., 2003, 48: 581-586.
73. TAKETA K. α-foetoprotein: reevaluation in hepatology. Hepatology, 1990, 12: 1420-1432.
74. SHERMAN M. α-foetoprotein: an obituary. J. Hepatol., 2001, 37: 603-605.
75. WEITZ I., LIEBNAN H. Des-J-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical review. Hepatology, 1993, 18: 990-997.
76. NOMURA T., JSHIJIMA M., HORIKOSHI A., NAKAI T., OHNISHI K. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay And two modified methods. Ann. J. Gastroenterol., 1996, 91: 1380-1383.
77. OKANO H., SHIRAKI K., INOUE H., ITO T., YAMANAKO T., DEGUCHI M., SUGIMOTO K., SAKAI T., OHMORI S., MURATA K., TAKASE K., NAKANO T. Comparison of screening methods for hepatocellular carcinoma in patients with cirrhosis. Anticancer Research, 2001, 21: 2979-2982.
78. VILANA R., BRUIX J., BRU C., AYUSO C., SOLE M., RODES J. Tumour size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology, 1992, 16: 353-357.
79. OHNISHI K., NOMURA F., ITO S., FUJIWARA K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology, 1996, 23: 994-1002.
80. KOMORIZONO Y., OKETANI M., SAKO K., YAMASAKI N., SHIBATOU T., MAEDA M., KOHARA K., SHIGENOBU S., ISHIBASHI K., ARIMA T. Risk factors for local recurrence of small hepatocellular carcinoma after a single session, single application of percutaneous radiofrequency ablation. Cancer, 2003, 97: 1253-1262.
81. TREVISANI F., DE NOTARIIS S., RAPACCINI G., FARINATI F., BENVEGNU L., ZOLI M., GRAZI C.-L., DEL POBBIO P., DINOLFO M.-A., BERNARDI M., and the Italian liver cancer group. Semi-annual and Annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival. Am. J. Gastroenterol., 2002, 97: 734-749.
82. MARRERO J., FONTANA R., SU G., CONJEENARAM H., EMICK D., LOK A. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology, 2002, 36: 1349-1354.
83. FEDERLE M. Use of radiological techniques to screen for hepatocellular carcinoma. J. Clin. Gastroenterol., 2002, 35 (suppl 2): S 92-S 100.
84. BRUIX J., SHERMAN M., LLOVET J., BEAUGRAND H., LENCIONI R., BURROUGHS A., CHRISTENSEN E., PAGLIARO L., COLOMBO M., RODES J. for the EASL panel of experts on HCC. Clinical management at hepatocellular carcinoma. Conclusions of the Barcelona - 2000 EASL conference. J. Hepatol., 2001, 35: 421-430.
85. FRANCQUE S., DE PAUW F., VAN DEN STEEN G., VAN MARCK E., PELCKMANS P., MICHIELSEN P. Biopsy of focal liver lesions: guidelines, comparison of techniques and cost-analysis. Acta Gastroenterol. Belg., 2003, 66: 160-165.
86. HUANG G.-T., SHEU J.-C., YANG P.-M., LEE H.-S., WANG T.-H., CHEN D.-S. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma - A study based on 420 patients. J. Hepatol., 1996, 25: 334-338.
87. TORZILLI G., MINAGAWA M., TAKAYAMA T., NOUE K., HUI A.-M., KUBOTA K., OHTONO K., MAKUUCHI M. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology, 1999, 30: 889-893.
88. DURAND F., REGIMBEAU J.-N., BELGHITI J., SAUVANET A., VILGRAIN U., TERRIS B., MOUTARDIE V., FARGES O., VALLA D. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J. Hepatol., 2001, 35: 254-258.
89. TERADA T., TERASAKI S., NAKANUMA Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined at autopsy. Cancer, 1993, 72: 1551-1556.
90. HYTIROGLOU P., THEISE N., SCHWARTZ M., MOR E., MILLER C., THUNG S. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology, 1995, 21: 703-708.
91. LE BAIL B., BELLEANNEE G., BERNARD P.-H., SARIC J., BALABAUD C., BIOULAC-SAGE P. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density and proliferative activity of 35 macronodular lesions in cirrhotic explants of 10 adult french patients. Hum. Pathol., 1995, 26: 897-906.
92. EARLS J., THEISE N., WEINREB J., DECORATO D., KRINSKY G., ROFSKY N., MIZRACHI H., TEPERMAN L. Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology, 1996, 201: 207-214.
93. BHATTACHARYA S., DHILLON A., REES J., SAVAGE J., BURROUGHS A., ROLLES K., DAVIDSON B. Small hepatocellular carcinoma in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology, 1997, 25: 613-618.
94. TAKAYAMA T., MAKUUCHI M., HIROHASHI S., SAKAMOTO M., OKAZAKI N., TAKAYASU K., KOSUGE T., MOTOO Y., YAMAZAKI S., HASEGAWA H. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet, 1990, 336: 1150-1153.
95. BORZIO M., BORZIO F., CROCE A., SALA M., SALNI A., LEANDRO G., BRUNO S., RONCALLI M. Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study. Gastroenterology, 1997, 112: 1617-1623.
96. MION F., GROZEL L., BOILLOT O., PALIARD P., BERGER F. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinoma. Gastroenterology, 1996, 111: 1587-1592.
97. SAADA J., BHATTACHARYA S., DHILLON A., DICK R., BURROUGHS A., ROLLES K., DAVIDSON B. Detection of small hepatocellular carcinoma in cirrhotic livers using iodised oil computed tomography. Gut, 1997, 41: 404-407.
98. FRACANZANI A.-L., BURDICK L., BORZIO M., RONCALLI M., BONELLI N., BORZIO F., MARASCHI A., FIORELLI G., FARGION S. Contrast-enhanced doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology, 2001, 34: 1109-1112.
99. HADENGUE A. Dépistage du carcinome hépatocellulaire: entre cynisme et angélisme? Gastroenterol. Clin. Biol., 2003, 27: 525-527.
100. WOLF A., BECKER D. Cancer screening and informed patient discussions. Truth and consequences. Arch. Intern. Med., 1996, 156: 1069-1072.
101. CHEN T., CHEN C.-J., YEN M.-F., LU S.-N., SUN C.-A., HUANG G.-T., YANG P.-M., LEE H.-S., DUFFY S. Ultrasound screening in a high risk group in Taiwan. Int. J. cancer, 2002, 98: 257-261.
102. MENAHON B., BULKOW L., HARSTER A., SNOWBALL M., LANIER A., SACCO F., DUNAWAY E., WILLIAMS J. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16 - year population - based study. Hepatology, 2000, 32: 842-846.
103. JOHNSON P. Hepatocellular carcinoma: is current therapy really altering outcome? Gut, 2002, 51: 459-462.
104. COTTONE M., VIRDONE R., FUSCO G., ORLANDO A., TURRI M., CALTAGIRONE H., MARINGHINI A., SCIARRINO E., DEMMA I., NICOLI N., TINE F., SAMMARCO S., PAGLIARO L. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology, 1989, 96: 1566-1571.
105. FAIVRE J., FORMAN D., ESTEVE J., OBRADOVIC M., SANT M. and the EUROCARE working group. - Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur. J. Cancer, 1998, 34: 2184-2190.
106. EL-SERAG H., MASON A., KEY C. Trends in survival of patients with hepatocellular carcinoma between 1977 and, 1996 in the United States. Hepatology, 2001, 33: 62-65.
107. HENRION J., LIBON E. Screening for hepatocellular carcinoma: a regained enthusiasm due to new therapeutic options? Acta Gastroenterol. Belg., 1995, 58: 426-432.
108. YUEN M.-F., CHENG C.-C., LAUDER J., LAM S.-K., OOI C., LAI C.-L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong-Kong experience. Hepatology, 2000, 31: 330-335.
109. GIANINI E., ARZANI L., BORRO P., BOTTA F., FASOLI A., RISSO D., CELLE G., TESTA R. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis. Hepato-Gastroenterol., 2000, 47: 1395-1398.
110. TAKAYAMA T., MAKUUCHI M., HIROHASHI S., SAKAMOTO M., YAMAMOTO J., SHIMADA K., KOSUGE T., OKADA S., TAKAYASU K., YAMASAKI S. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology, 1998, 28: 1241-1246.
111. LIVRAGHI T., GIORGIO A., MARIN G., SALMI A., DESIO I., BOLONDI L., POMPII H., BRUNELLO F., LAZZARONI S., TORZILLI G., ZUCCHI A. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology, 1995, 197: 101-108.
112. DANIELE B., DESTO I., IZZO F., CAPUANO G., ALDREANA A., MAZZANT R., AIELLO A., VALLONE P., FIORE F., GAETA G.-B., PERRONE F., PIGNATA S., GALLO C. On behalf of the CLIP investigations. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A cancer of the liver Italian program (CLIP 08). Retrospective case-control study. J. Clin. Gastroenterol., 2003, 36: 63-67.
113. MAZZAFERRO V., REGALIA E., DOCI R., ALDREOLA S., PULVIRENTI A., BOZZETTI F. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N. Engl. J. Med., 1996, 334: 693-699.
114. EBARA M., HATANO R., FUKUDA H., YOSHIKAWA M., SUGIURA N., SAISHO. Natural course of small hepatocellular carcinoma with underlying cirrhosis: a study of 30 patients. Hepato-Gastroenterol., 1998, 45 (suppl 3): 1214-1220.
115. LIVRAGHI T., BOLONDI L., BUSCARINI L., COTTONE M., MAZZIOTTI A., MURABITO A., TORZILLI G. and the Italian cooperative HCC study group. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J. Hepatol., 1995, 22: 522-526.